截至2025 年7 月31日， 花旗集团 将其在 凯莱英 医药集团（Asymchem Laboratories Tianjin Co Ltd）的非净空头头寸减少 20.53%，至 589,675 股，占该公司股票的 2.14%。根据监管披露信息，至少有四名投资者披露了对总部位于中国天津的凯莱英的空头头寸。已披露的空头头寸共计 109 万股，占该公司流通股的 3.95%。花旗集团持有最大的空头头寸。...
Source Link截至2025 年7 月31日， 花旗集团 将其在 凯莱英 医药集团（Asymchem Laboratories Tianjin Co Ltd）的非净空头头寸减少 20.53%，至 589,675 股，占该公司股票的 2.14%。根据监管披露信息，至少有四名投资者披露了对总部位于中国天津的凯莱英的空头头寸。已披露的空头头寸共计 109 万股，占该公司流通股的 3.95%。花旗集团持有最大的空头头寸。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.